Free Trial

Monogram Orthopaedics (NASDAQ:MGRM) Trading Up 0.3% - Time to Buy?

Monogram Orthopaedics logo with Medical background

Key Points

  • Monogram Orthopaedics shares rose by 0.3% to $5.91 during trading, with a significant drop in trading volume of 26% compared to its average.
  • The company reported a quarterly earnings per share (EPS) of ($0.16), missing analysts’ expectations of ($0.11).
  • Several institutional investors increased their holdings in Monogram Orthopaedics, with Jane Street Group LLC raising its position by 83.0% in the first quarter.
  • Five stocks we like better than Monogram Orthopaedics.

Monogram Orthopaedics Inc. (NASDAQ:MGRM - Get Free Report) shares shot up 0.3% during trading on Friday . The company traded as high as $5.92 and last traded at $5.91. 70,858 shares traded hands during trading, a decline of 26% from the average session volume of 95,196 shares. The stock had previously closed at $5.89.

Monogram Orthopaedics Stock Up 0.3%

The stock's 50-day moving average price is $5.64 and its 200 day moving average price is $3.86. The firm has a market cap of $240.14 million, a price-to-earnings ratio of -11.82 and a beta of 0.69.

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last announced its quarterly earnings data on Friday, August 15th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.05). On average, research analysts predict that Monogram Orthopaedics Inc. will post -0.49 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Orion Porfolio Solutions LLC raised its position in shares of Monogram Orthopaedics by 15.4% during the second quarter. Orion Porfolio Solutions LLC now owns 13,850 shares of the company's stock valued at $40,000 after buying an additional 1,850 shares during the last quarter. Crestwood Advisors Group LLC acquired a new position in shares of Monogram Orthopaedics during the second quarter valued at about $29,000. Jane Street Group LLC raised its position in shares of Monogram Orthopaedics by 83.0% during the first quarter. Jane Street Group LLC now owns 19,426 shares of the company's stock valued at $57,000 after buying an additional 8,810 shares during the last quarter. Focus Partners Advisor Solutions LLC raised its position in Monogram Orthopaedics by 6.1% in the first quarter. Focus Partners Advisor Solutions LLC now owns 213,678 shares of the company's stock worth $628,000 after purchasing an additional 12,328 shares in the last quarter. Finally, Northern Trust Corp raised its position in Monogram Orthopaedics by 110.6% in the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company's stock worth $109,000 after purchasing an additional 24,088 shares in the last quarter. Institutional investors and hedge funds own 0.45% of the company's stock.

About Monogram Orthopaedics

(Get Free Report)

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Monogram Orthopaedics Right Now?

Before you consider Monogram Orthopaedics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monogram Orthopaedics wasn't on the list.

While Monogram Orthopaedics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.